[144] Veris Residential, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Veris Residential, Inc. (VRE) records a proposed sale of 64,080 common shares through Morgan Stanley Smith Barney LLC, with an approximate aggregate market value of $1,028,093.11 and an indicated approximate sale date of 09/10/2025. The filing states these shares were acquired in the open market on 05/21/2018 with cash payment completed on 05/23/2018. The form also discloses recent related sales: MIRELF VI REIT INVESTMENT II, LLC sold 64,080 shares on 09/09/2025 for gross proceeds of $1,032,924.74, and MIRELF VII US SECURITIES LLC sold 85,920 shares on 09/09/2025 for gross proceeds of $1,384,970.29. The filer affirms no undisclosed material adverse information and warns of criminal penalties for misstatements.

Positive

• Compliance disclosure filed under Rule 144 providing required transaction details
• Broker and counterparty identified (Morgan Stanley Smith Barney LLC) enabling market transparency

Negative

• Insider/affiliate selling activity disclosed (64,080 shares proposed; additional 150,000 shares sold by affiliated entities), which may indicate insider liquidity
• No explanatory context provided for the affiliated entity sales in the filing text

Insights

Financial Analyst

TL;DR: Routine Rule 144 insider sale disclosed; transaction size appears small relative to shares outstanding.

The Form 144 shows a proposed brokered sale of 64,080 common shares valued at about $1.03 million, with the registrant's total shares outstanding listed as 93,421,769. The shares were acquired in 2018 and paid for in cash. The filing also reports related entity sales on 09/09/2025 totaling 150,000 shares across two entities for roughly $2.42 million. From a financial-materiality perspective, the single proposed sale represents a small fraction of outstanding shares, suggesting limited direct market impact. The filing is a compliance disclosure under Rule 144 and provides transaction dates, counterparties, and proceeds that allow reconciliation of recent insider/affiliate liquidity events.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 requirements but highlights affiliated-entity sales worth noting for governance monitoring.

The notice includes required representations that no undisclosed material information exists and references potential 10b5-1 plan considerations. Separate sales by MIRELF-affiliated entities on 09/09/2025 are reported and should be tracked by governance teams to ensure trading plans and disclosure timing align with internal policies. The filing contains acquisition, payment, broker, and proceeds details enabling oversight of insider or affiliate dispositions, but it does not provide any accompanying explanatory context for the sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	64080	1028093.11	93421769	09/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/21/2018	Open Market Purchase	Open Market			64080	05/23/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	64080	1032924.74
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	85920	1384970.29

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for VRE report?

The filing reports a proposed sale of 64,080 VRE common shares via Morgan Stanley Smith Barney LLC with an aggregate market value of $1,028,093.11 and an approximate sale date of 09/10/2025.

When were the shares to be sold originally acquired?

The shares were acquired in an open market purchase on 05/21/2018, with payment noted as completed in cash on 05/23/2018.

Were there any recent related sales reported?

Yes. The filing lists sales on 09/09/2025 by MIRELF VI REIT INVESTMENT II, LLC (64,080 shares, gross proceeds $1,032,924.74) and MIRELF VII US SECURITIES LLC (85,920 shares, gross proceeds $1,384,970.29).

Who is the broker handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

How many shares outstanding does the filing show for the issuer?

The filing lists 93,421,769 shares outstanding for the issuer.

Does the filer confirm no undisclosed material information?

Yes. The filer represents by signature that they do not know any material adverse information about the issuer that has not been publicly disclosed.